Smart Symptom Tracking ALEX Application for Tracking and Monitoring Gastrointestinal Health, Smart Horizons Pilot Trial
Part of paid clinical trials in Jacksonville, Florida.
- Sponsor
- Mayo Clinic
- Study ID
- NCT07618273
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 44 Years
- Healthy Volunteers
- Accepted
Interventions
- Artificial Intelligence-based Intervention — OTHEREngage with the Smart Symptom Tracking ALEX app
- Best Practice — OTHERComplete paper logs
- Communication Intervention — OTHERReceive reminders
- Questionnaire Administration — OTHERAncillary studies
Study Details
This clinical trial compares the impact of the Smart Symptom Tracking ALEX application (app) to standard symptom-tracking practices in tracking and monitoring gastrointestinal (GI) symptoms in young adults. Rates of early-onset colorectal cancer are rising sharply and it is projected to become the leading cause of cancer-related death in young adults. Despite this, adults under 45 still face barriers to diagnosis, including access to screening, unclear guidance on the impact of GI symptoms and dismissal of symptoms by healthcare providers. Current screening guidelines lack guidance on monitoring early symptoms in younger adults. The Smart Symptom Tracking ALEX tool is a digital platform that uses artificial intelligence to provide prompts for symptoms, coaching, reminders and education. Standard of care clinical practices include paper-based logs to report symptoms. Using the Smart Symptom Tracking ALEX app may provide more detailed symptom reports and increase self-reported symptom communication compared to standard symptom-tracking practices in young adults concerned about their GI health.
Key Dates
- Start date
- Apr 20, 2026
- Status verified
- Jun 2026
- Primary completion
- Apr 20, 2027
- Completion
- Apr 20, 2029
Study Design
- Enrollment
- 50 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SCREENING
Arms
- Experimental: Arm 1 (Smart Symptom Tracking ALEX)Participants engage with the Smart Symptom Tracking ALEX app daily and receive reminders weekly for 4 weeks.
- Active Comparator: Arm 2 (paper logs)Participants complete paper logs daily and receive reminders weekly for 4 weeks.
Primary Outcome Measure
Change in gastrointestinal self-advocacy [ Time Frame: At baseline and at 4 weeks ]
Central Contacts
- Enhancing Technology & Communication in Healthcare (ETCH) Lab904-953-5375
- Clinical Trials Referral Office855-776-0015
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic in Florida | Jacksonville | Florida | 32224-9980 | Janice L. Krieger, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Jacksonville, FL
Related Studies
- Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome PatientsRecruiting · Mayo Clinic · Scottsdale, Arizona
- A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H MutationPHASE1 · Recruiting · AstraZeneca · Gilbert, Arizona
- Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid TumorsPHASE1 · Recruiting · AstraZeneca · Duarte, California
- Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology ClinicsRecruiting · Wake Forest University Health Sciences · Fairbanks, Alaska